New use for once-cursed drug Thalidomide?

Apr 04, 2010

Thalidomide, the sedative blamed for tragic birth defects half a century ago, treated a rare inherited blood disorder, according to lab experiments reported on Sunday.

Around one person in 10,000 has a disorder called hereditary haemorrhagic telangiectasia, or HHT, which causes frequent, hard-to-treat nosebleeds.

French doctors, experimenting on mice genetically engineered to have HHT, found that reduced the risk of haemorrhage and stabilised blood vessels.

The drug works by boosting a protein called PDGF-B, the team from the National Institute of Health and Medical Research (Inserm) report in the journal Nature Medicine.

The work is experimental, aimed at showing the pathways by which HHT could be cured.

Thalidomide was sold between 1957 and 1961 until it was found that pregnant women who took the drug for morning sickness were at high risk of having a child missing a limb or having stunted arms.

More than 10,000 babies, especially in Germany, Britain, Australia and Canada, were affected.

The scandal led to a tightening of vetting procedures for drug prototypes and scrutiny of claims by pharmaceutical giants.

Thalidomide remains outlawed for general distribution.

In recent years, though, interest in it has revived as a research tool but also as a treatment for a form of cancer called and side-effects from . It is prescribed to patients only in very tightly-controlled conditions.

Explore further: Risk of antibiotic overuse in aged care settings

add to favorites email to friend print save as pdf

Related Stories

Japan team uncovers thalidomide mystery

Mar 12, 2010

Japanese scientists have uncovered how thalidomide led to deformities in children born to mothers taking the drug in the 1950s and 1960s, according to a study released Friday.

New insights into thalidomide-birth defect episode

Nov 10, 2008

Scientists in Germany have discovered why the medication thalidomide appeared safe in animal tests before going on the market 50 years ago, only to cause perhaps the most extensive outbreak of drug-induced birth defects in ...

Solving the 50-year-old puzzle of thalidomide

Nov 17, 2009

Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published ...

Japan may regulate thalidomide

Jun 13, 2006

Doctors in Japan will be required to register patients who are using the drug thalidomide under proposed regulations, the Japan Times reported.

Thalidomide film to air in Germany

May 19, 2007

A film about the drug thalidomide, which caused thousands of children to be born disabled, will air on German television.

Recommended for you

Risk of antibiotic overuse in aged care settings

22 hours ago

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

Ruconest approved for rare genetic disease

Jul 17, 2014

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

NIH system to monitor emerging drug trends

Jul 17, 2014

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

Novartis to use Google technology for eye care

Jul 15, 2014

Swiss drug developer Novartis will team with technology giant Google to develop a "smart" contact lens that could improve some eye conditions or help diabetics manage their disease.

User comments : 0